MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Relapsing Multiple Sclerosis

  1. Home
  2. Diseases
  3. Relapsing Multiple Sclerosis
  4. Clinical Trials

Clinical Trials Related to Relapsing Multiple Sclerosis

Related studies linked through entity extraction aliases.

NCT00906399

Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis

Status
COMPLETED
Phase
PHASE3

NCT00853762

Atacicept in Multiple Sclerosis Extension Study, Phase II

Status
TERMINATED
Phase
PHASE2

NCT00726648

CDP323 Biomarker Study

Status
COMPLETED
Phase
PHASE1/PHASE2

NCT00642902

A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS)

Status
TERMINATED
Phase
PHASE2

NCT00619307

Transition to Rebif New Formulation

Status
COMPLETED
Phase
PHASE3

NCT00472797

Rebif New Formulation (RNF) Quality of Life (QOL) Study

Status
COMPLETED
Phase
PHASE3
Previous

Next

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.